Zivo Bioscience Registration Statement Effective April 1, 2026
Ticker: ZIVO · Form: EFFECT · Filed: 2026-04-02T00:15:07-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, securities-offering
TL;DR
ZIVO registration statement effective 4/1/26 - ready to sell shares!
AI Summary
Zivo Bioscience, Inc. filed an EFFECT form, indicating that a registration statement related to their securities has become effective. The effectiveness date is April 1, 2026, with the filing accepted on April 2, 2026. The company's mailing and business address is 21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI 48304.
Why It Matters
This filing signifies that Zivo Bioscience, Inc. can now proceed with the sale of securities as outlined in their registration statement, potentially impacting its capital structure and future operations.
Risk Assessment
Risk Level: medium — The effectiveness of a registration statement is a procedural step, and the actual success of the securities offering and the company's future performance carry inherent risks.
Key Numbers
- 2026-04-01 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-02 — Filing Acceptance Date (The date the SEC accepted the filing.)
Key Players & Entities
- Zivo Bioscience, Inc. (company) — Filer
- 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (address) — Mailing and Business Address
- 0001101026 (company_id) — CIK
- 333-273493 (file_number) — Act 33 File Number
FAQ
What type of securities are being registered by Zivo Bioscience, Inc.?
The filing does not specify the type of securities being registered, only that the registration statement has become effective.
What is the purpose of this EFFECT filing?
An EFFECT filing signifies that a registration statement filed with the SEC has become effective, allowing the company to proceed with the sale of the registered securities.
When did Zivo Bioscience, Inc. file its initial registration statement?
The filing does not provide the date of the initial registration statement filing, only the effectiveness date of April 1, 2026.
What is the company's SIC code and industry classification?
The company's SIC code is 2836, classified under Biological Products, (No Diagnostic Substances), within the Life Sciences sector.
Where is Zivo Bioscience, Inc. incorporated?
Zivo Bioscience, Inc. is incorporated in Nevada (NV).
From the Filing
EDGAR Filing Documents for 9999999995-26-001036 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001036 Accepted 2026-04-02 00:15:07 Documents 1 Effectiveness Date 2026-04-01 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 604 Complete submission text file 9999999995-26-001036.txt 2008 Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866 Zivo Bioscience, Inc. (Filer) CIK : 0001101026 (see all company filings) EIN. : 870699977 | State of Incorp.: NV | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-273493 | Film No.: 26830442 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)